Dissecting T-cell exhaustion heterogeneity and immune ecosystem dynamics in colorectal cancer through multi-omics

Zhijing Zhang1,2, Peng Ouyang3, Kai Cui2

  • 1Department of General Surgery, The First Affiliated Hospital of Jinan University, 613 W. Huangpu Avenue, Guangzhou, 510630, China.

BMC Cancer
|June 19, 2026
PubMed
Abstract

Insights

T-cell exhaustion (TEX) drives immunotherapy resistance in colorectal cancer (CRC). A novel five-gene TEX score predicts poor prognosis, aiding patient stratification for better treatment strategies.

Area of Science:

  • Oncology
  • Immunology
  • Genomics

Background:

  • Immunotherapy exhibits limited efficacy in a significant portion of colorectal cancer (CRC) patients.
  • Mechanisms of therapeutic resistance in CRC are not fully understood.
  • T-cell exhaustion (TEX) in the tumor microenvironment is a key factor in immune evasion and tumor progression.

Purpose of the Study:

  • To investigate the role of T-cell exhaustion (TEX) in colorectal cancer (CRC).
  • To identify core genes associated with CD8+ T-cell exhaustion.
  • To develop a predictive model for immunotherapy response in CRC patients.

Main Methods:

  • Integrated single-cell RNA sequencing (scRNA-seq) and bulk transcriptomic data.
  • Utilized hdWGCNA and ten machine learning algorithms to identify core exhaustion genes.
  • Constructed and validated a multivariate Cox-based TEX score model across independent cohorts and immunotherapy datasets.
  • Experimentally validated findings using RT-qPCR, Western blot, and quantitative multiplex immunofluorescence.

Main Results:

  • Identified a continuum of intra-tumoral CD8+ T-cell exhaustion states.
  • Developed a five-gene TEX score (KLF3, LMNA, SLC2A3, ARL4C, TIMP1) that predicts poor prognosis.
  • The TEX score correlates with an immunosuppressive tumor microenvironment.
  • Confirmed differential gene expression and spatial co-localization with CD8+ T cells in clinical CRC specimens.

Conclusions:

  • T-cell exhaustion (TEX) is implicated as a central mediator of immunotherapy resistance in colorectal cancer (CRC).
  • The developed TEX score offers a clinically actionable framework for patient stratification.
  • Findings support improved therapeutic decision-making for CRC patients undergoing immunotherapy.

Related Concept Videos